| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Buprenorphine | FAERS: 4 | OFFSIDES US FAERS | |
| 2 | Risperidone | FAERS: 3 | US FAERS | |
| 3 | PCI 32765 | FAERS: 2 | US FAERS | |
| 4 | Warfarin | FAERS: 2 | US FAERS | |
| 5 | 3-ingenyl angelate | FAERS: 1 | US FAERS | |
| 6 | Amphetamine | FAERS: 1 | US FAERS | |
| 7 | Buprenorphine | FAERS: 1 | US FAERS | |
| 8 | Mitomycin | FAERS: 1 | US FAERS | |
| 9 | Trazodone | FAERS: 1 | US FAERS | |
| 10 | Trazodone | FAERS: 1 | US FAERS | |
| 11 | Warfarin | FAERS: 1 | US FAERS | |
| 12 | eltrombopag | FAERS: 1 | US FAERS | |
| 13 | regorafenib | FAERS: 1 | US FAERS | |
| 14 | reviparin | FAERS: 1 | US FAERS | |
| 15 | Cytarabine | OFFSIDES | ||
| 16 | Daunorubicin | OFFSIDES | ||
| 17 | Sitagliptin Phosphate | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120242
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.